期刊
INTERNATIONAL IMMUNOPHARMACOLOGY
卷 20, 期 1, 页码 148-156出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2014.02.030
关键词
Selective serotonin reuptake inhibitors; Immunosuppression; Lymphocytes; Autoimmune diseases; Graft-versus-host disease
In the past decades, selective serotonin reuptake inhibitors (SSRIs) have been shown to exert several immunological effects, such as reduced lymphocyte proliferation, alteration of cytokine secretion and induction of apoptosis. Based on these effects, SSRIs were proposed as drugs for the treatment of autoimmune pathologies and graft-versus-host disease. This review summarizes preclinical and clinical evidence supporting a role for SSRIs in autoimmune diseases and graft-versus-host disease, and discusses what is known about the mechanism underlying these effects. (C) 2014 The Authors. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据